T standard terminology to facilitate patient counseling,
|
|
- Annabel Higgins
- 7 years ago
- Views:
Transcription
1 Prognostic Factors in Mobile Tongue and Floor of Mouth Carcinoma BERT BROWN, MD,* LEON BARNES, MD,t JUAN MAZARIEGOS, MD,t FLOYD TAYLOR, ScD,$ JONAS JOHNSON, MD,* AND ROBIN L. WAGNER, BS' This study identifies significant prognostic factors in squamous cell carcinomas of the anterior tongue and floor of mouth. It is clear that the TMN staging system does not account for other important variables that affect tumor prognosis. Tumor thickness and the presence of perineural invasion and intralymphatic tumor emboli should be examined in all resected tumors. Tumor thickness, tumor size, and perineural invasion all have an impact on survival and must be considered in treatment plans. Tumors measuring between 2 mm and 3 mm may or may not have metastases and further evaluation of this group needs to be done. Most importantly, the data in this study supports a multiinstitutional prospective evaluation of pathology specimens. Precise guidelines must be established for handling of the specimen, which must then be evaluated for the variables mentioned above. In this way, more definitive conclusions can be reached in the management of tumors of the anterior tongue and floor of mouth. Cancer 64: ,1989. HE TNM STAGING SYSTEM is intended to provide T standard terminology to facilitate patient counseling, therapeutic decision-making, and comparison of results of treatment. To improve the usefulness of the staging system, a retrospective study was undertaken to evaluate the effect of tumor thickness, perineural invasion, and intravascular and intralymphatic tumor emboli on subsequent outcome after treatment. Pathologic specimens were reviewed without the knowledge of clinical course. All patients were followed a minimum of 2 years after completion of therapy. Appropriate pathologic material and clinical follow-up were available on 87 patients with squamous cell carcinoma of the mobile tongue and anterior floor of mouth. Increases in tumor thickness were correlated with decreased survival for death from all causes as well as for death from disease. Patients with tumor thickness less than or equal to 3 mm had improved survival (P = ) when compared to patients with tumor thickness between 3 mm and 7 mm and those with tumor thickness greater From the *Department of Otolaryngology, University of Pittsburgh School of Medicine, Eye and Ear Hospital of Pittsburgh, Pittsburgh; the?department of Pathology, University of Pittsburgh School of Medicine, Presbyterian-University Hospital, Pittsburgh; and the $Department of Community Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. Address for reprints: Jonas T. Johnson, MD, Professor and Vice Chairman, Department of Otolaryngology, Eye and Ear Institute, Suite 500, 203 Lothrop Street, Pittsburgh, PA Accepted for publication March 13, than 7 mm. Multivanant analysis revealed that perineural invasion (P = O.OOl), intralymphatic tumor emboli (P = 0.006), and tumor stage (P = 0.012) were associated with the development of cervical metastasis. These data are in keeping with observations made by other investigators supporting the need for the integration of pathologic information into therapeutic decision-making. Close cooperation between surgeons and pathologists is critical to facilitate consistently reliable pathologic data. The TNM staging system provides standard terminology for patient counseling, therapeutic decision-making, and reporting end results. The clinical stage, however, does not reliably predict prognosis. Previous studies have suggested that there are other variables, not included in the TNM system, that correlate with tumor behavior. In particular, tumor thickness and perineural invasion of tumor were shown to correlate statistically with both survival and locoregional recurrence. Other variables such as intralymphatic and intravascular tumor emboli have also been considered as potential prognostic factors.6 The goal of this study was to further evaluate tumor thickness, perineural invasion, and intravascular and intralymphatic tumor emboli to determine if they could be correlated with tumor recurrence and survival. A better predictor of metastasis and prognosis would allow improved planning of therapy and avoid unnecessary neck dissections or radiotherapy. A retrospective review of both clinical and pathologic data on surgically treated anterior tongue and floor of mouth squamous cell carcinomas was, therefore, undertaken. 1195
2 1196 CANCER September Vol. 64 FIG. 1. Diagram of methods of measurement of tumor thickness. Materials and Methods The hospital charts of all patients who had surgery for squamous cell carcinoma of the anterior tongue or floor of mouth between 1974 and 1984 were reviewed. Only those patients who had surgery as their first treatment modality were included. In addition, only those patients who had documented follow-up for 2 years or more and had all pathologic slides (including the original biopsy) available for review were eligible for the study. All pathology slides were reviewed with the pathologist. An ocular micrometer was used to measure the maximal thickness of tumor to the nearest millimeter, measuring vertically from the surface of the tumor. All measurements were taken from the most perpendicular cuts available. Surface keratin, parakeratin, and inflammatory exudate were not included in the measurement. In those cases where the tumor was exophytic, a measurement was taken from the tip of the papilla to maximal depth in a radial fashion (Fig. 1, diagram 1). In the case of an ulcerative tumor, a measurement was made from the ulcer base in a radial fashion to the deepest penetration of tumor (Fig. 1, diagram 2, measurement B). In addition, attempts were made to draw an imaginary mucosal line over the ulcer to the outer cellular limits of the adjacent intact mucosa, and then take measurements from this line to the deepest point of invasion (Fig. 1, diagram 2, measurement C). Comparisons were made between the depths obtained using an imaginary mucosal line versus depth from the ulcer base. Perineural invasion was defined as tumor invasion of the perineural sheath and/or epineurium (Fig. 2). To qualify as an intravascular or intralymphatic tumor embolus, the tumor cells had to be either associated with FIG. 2. Perineural and early intraneural invasion (arrow) (H & E, X3 15).
3 No. 6 PROGNOSTIC FACTORS IN TONGUE AND MOUTH CA h ~ wet n a/ FIG. 3. Vascular invasion. Notice the points of attachment of the tumor to the vascular wall (arrows) and early fibrin deposition (asterisk) (H & E, X315). fibrin deposits (thrombus) or attached to the wall of the vessel (Figs. 3 and 4). In the case of metastatic disease, tumor within the lymph nodes were confirmed, and the presence or absence of extracapsular spread outside of the lymph node was recorded. Classes of tumor thickness were created using the data obtained from the ocular micrometer measurements. Tu- mors were grouped into the following thickness categories: Class A, 0 to I 3 mm; Class B, > 3 mm I 7 mm; and Class C, > 7 mm. The impact of tumor stage, tumor thickness, perineural invasion, intralymphatic and intravascular emboli, cervical metastases, and extracapsular nodal spread on survival was assessed by univariate analysis using the Kaplan- FIG. 4. Lymphatic invasion (H & E, X315).
4 1198 CANCER September Vol. 64 TABLE 1. Tumor Staging* both for those variables assessed with survival and those Tumor size assessed for regional recurrence. Nodal status T1 T2 T3 T4 NO N N N Total * All tumors were MO. Meier product limit method. The generalized Wilcoxon test was then used to determine statistical significance. The relationship of tumor location, tumor stage, tumor thickness, perineural invasion, and intralymphatic and intravascular tumor emboli to the occurrence of metastatic disease in clinically NO necks was assessed. This included patients found to have metastatic lymph nodes by elective neck dissection at the time of initial surgery, and those who were observed and later developed metastatic disease in the neck. Chi-square analysis was performed to assess statistical significance. The relationship of tumor thickness and tumor stage to perineural invasion and intralymphatic and intravascular tumor emboli was also assessed and tested for significance with chi-square analysis. Multivariate analysis was done using stepwise logistic regression Total patients Dead of disease 2... L-, : Total patients 35/ Dead of disease 13 cn! 4 w 2.40 = L - - -Total patients 101 Dead of disease SURVIVAL IN MONTHS T, = T, = T, P VALUE =,0009 FIG. 5. Life tables. Tumor size: death from tumor. Results One hundred forty-seven patients were initially evaluated. Of these, 87 patients met all necessary criteria for inclusion in the study. This included 39 tumors of the floor of mouth and 48 tumors of the anterior tongue. The patients ranged in age from 50 to 70 years. There were 30 women and 57 men. Size of Primary Tumor There were 30 TI tumors, 43 T2 tumors, ten T3 tumors, and four T4 tumors (Table 1). No patients had distant metastases at diagnosis. All were followed greater than 2 years after surgery. In patients who were initially staged NO, regional metastases were discovered by elective neck dissections or developed during the follow-up period in eight of 29 (28%) TlNO tumors, 20 of 37 (54%) T2NO tumors, four of five (80%) T3NO tumors, and zero of 23 T4NO tumors. The difference was statistically significant with P = Nine patients with T1 tumors died, seven from other causes and two from disease (adjusted survival, 2 1/23; 9 1 %). Of the two patients who died from disease, one died of local recurrence and, on review of the pathology slides, was found to have a positive margin. The other patient died of regional disease and had a 6-mm thick tumor. Twenty-one patients with T2 tumors died, 13 from disease and eight from other causes (adjusted survival, 22/35; 63%). Of the 13 who died from disease, one died of local disease, seven died of regional disease, four died with local, regional, and distant disease, and one died of regional and distant disease. Four patients with T3 tumors died, all from disease (survival, six often; 60%). A local recurrence was noted in one patient; regional disease developed in four patients. All patients with T4 tumors died of other causes. A significant decrease in survival with increasing tumor stage was seen both for death from all causes (P = 0.01) and death due to disease (P = ) (Fig. 5). In patients dead of disease, there was a significant difference between T1 and T2 tumors (P = 0.01). There was not a statistical difference in survival between T2 and T3 tumors (P > 0.05). There were too few T4 tumors for statistical analysis. Classes of Tumor Thickness Distribution of tumor thickness by tumor stage is seen in Table 2. There were 25 patients in Class A, 33 patients in Class B, and 29 patients in Class C. In those patients
5 No. 6 PROGNOSTIC FACTORS IN TONGUE AND MOUTH CA * Brown et d TABLE 2. Thickness Class by Tumor Size Tumor size Depth Class (mm) TI T2 T3 T4 A 0 to B >3 to C > clinically staged NO, nine of 24 patients (38%) in Class A developed regional disease as did 12 of 29 (41%) in Class B and 1 I of 20 (55%) in Class C. The presence of regional disease was not statistically different among classes of tumor thickness (P = 0.48) (Table 3). In Class A, eight patients died, one from recurrent local disease and seven (39%) from other causes. Adjusted survival with a minimum of 2 years follow-up was 94% (17/ 18 patients). In Class B, eight patients died of tumor, whereas seven (27%) died of other causes. Two-year determinate survival was 69% (1 8/26 patients). Of those patients who died from tumor, one had a local recurrence, seven patients had regional recurrences, and two patients had distant metastases. In Class C, ten patients died of disease, whereas five (21%) died of other causes. The 2- year determinate survival was 58% (14/24 patients). Of the ten patients who died of disease, there were four local recurrences and nine regional (one contralateral) recurrences. Increases in tumor thickness were significantly correlated with decreased survival for death from all causes (P = 0.004) as well as death from disease (P = 0.001) (Fig. 6). Although Class A survival was statistically improved compared to Class B (P = ), the difference between Class B and Class C only approached statistical significance (P = 0.053). Perineural Invasion Twenty-six of 87 patients (30%) demonstrated perineural invasion. In patients initially staged NO, 12 of 17 patients (7 I %) with perineural invasion developed regional disease, whereas 20 of 56 patients (36%) without perineural invasion developed regional disease. This difference was statistically significant (P = 0.01) (Table 3). Of the 26 patients with perineural invasion, I I died from recurrent disease and three died from other causes. Adjusted 2-year survival was 52% (1 2/23 patients). Of those patients who died from tumor, two died from local disease, seven died from regional disease (one patient with recurrence in the contralateral neck), and two died from locoregional disease. Of those 61 patients without perineural invasion, 16 (26%) died of other causes whereas TABLE 3. Prognostic Factors for Development of Regional Disease in NO Necks No. with regional Total P Variable disease patients Percent value T1 T2 T3 T4 Thickness class A Thickness class B Thickness class C Perineural invasion Intralymphatic tumor emboli Regional disease: those patients with positive nodes after elective neck dissection and those patients who were observed and then developed regional recurrence. eight died of disease for an adjusted survival of 82% (37/ 45 patients). Perineural invasion had a statistically significant decrease in survival in both death from all causes (P = 0.04) and death due to disease (P = , Fig. 7). Intralymphatic Tumor Emboli Eleven of 87 patients ( 13%) had intralymphatic tumor emboli. Of those patients with NO necks, seven of eight (88%) with intralymphatic emboli developed regional dis- (I) z _.. L- 1 I Total patients 181 Dead of Disease 1 :.. Total patients 26/ Dead of disease 8 L - -. Total patients 241 I- Dead of Disease 10 W W A01 g a O.OL0 ' 2b. I i Thickness Class B = 3.1 to Thickness Class A = 0 to =3mm = 7mm ---- Thickness Class C = 7mm P VALUE =,001 4b. ' sb. I ab. I Id0 ' 40 ',do' SURVIVAL IN MONTHS FIG. 6. Life tables. Classes of tumor thickness: death from tumor.
6 1200 CANCER September Vol r, r, -I b. - I Total patients 451 I Dead of disease 8 1? b7 L-- 1 I I Total patients 23/ Dead of disease PRESENCE OF PERINEURAL INVASION - ABSCENCE OF PERINEURAL INVASION P VALUE = ot I I I I I I 1 1 I " I ' I SURVIVAL IN MONTHS FIG. 7. Life tables. Perineural invasion: death from tumor. ease whereas 25 of 65 (38%) without intralymphatic tumor emboli developed regional disease. The difference was highly significant (P = 0.006) (Table 3). Three of 11 patients died from tumor whereas two ( 18%) died from other causes. Two-year determinate survival was 67% (six of nine patients) in patients with intralymphatic tumor emboli as compared to 73% (43/59) in patients without tumor emboli. This difference is not statistically significant. Intravasciilar Tumor Emboli Only three patients had intravascular tumor emboli and no patients died during the study. Therefore, this variable was not used in any statistical analysis. Lymph Nodes With Extracapsular Spread Only eight patients had lymph nodes with extracapsular spread identified after a neck dissection. Of those patients, TABLE 4. Elective Neck Dissection Versus Observation Total patients DOD patients Percent Group Group I1 P value = 0.89 Group 1: patients with initial elective neck dissection; Group 2: patients necks observed initially; DOD: dead of disease. - two died from disease and two died of other causes. Both patients who died from disease had regional recurrence. The small numbers precluded statistical analysis. Multivariate Analysis of Survival Multivariate analysis with the covariates: Class of tumor thickness, tumor stage, perineural invasion, intralymphatic tumor emboli, initial nodal status, and extracapsular spread for death from tumor was performed. Only the class of tumor thickness was statistically significant (P = 0.002). The results were unchanged when looking at only the covariates: class of tumor thickness, tumor stage, and perineural invasion. Multivariate Analysis of Regional Recurrence Analysis of the covariates: Class of tumor thickness, perineural invasion, tumor size, and intralymphatic tumor emboli for the development of regional disease was performed. Analysis of all patients, including those with clinically positive nodes on initial exam, revealed that perineural invasion (P = 0.001), intralymphatic tumor emboli (P = 0.006), and tumor stage (P = ) were significantly associated with regional disease. The classes of tumor thickness did not show a statistical correlation with regional recurrence. Multivariate analysis was also performed using the covariates above to address patients with clinically negative necks only. In that analysis, intralymphatic tumor emboli (P = 0.006), perineural invasion (P = 0.009), and tumor stage (P = 0.017) were still significant variables for the development of regional recurrence. Elective Neck Versus Observation The survival of those patients who had elective neck dissections with occult positive nodes (Group I) versus those patients who were observed, developed regional recurrence, and subsequently received treatment (Group 11) was compared. Unfortunately, the patient population is too small to allow meaningful statistical analysis. Table 4 shows the numbers obtained in Group I; nine of 21 patients (43%) died from disease. In Group 11, two of seven patients died from disease (29%). This suggests decreased survival in patients who were observed initially until disease recurred in the neck. Finally, tumor thickness and tumor size were correlated with perineural invasion and intralymphatic tumor emboli. The class of tumor thickness showed a significant correlation with perineural invasion (P = 0.00 l), although there was no significant correlation with intralymphatic tumor emboli (Table 5). Tumor size showed no significant correlation with intralymphatic tumor emboli or perineural invasion.
7 No. 6 PROGNOSTIC FACTORS IN TONGUE AND MOUTH CA * Brown et d Discussion This study evaluated multiple factors that have been considered relevant in predicting survival and recurrence of squamous cell carcinoma of the head and neck. In univariate analysis, tumor thickness, tumor size (T stage), and perineural invasion all showed a statistically significant correlation with survival. Tumor thickness, however, was not correlated with the development of regional recurrence. Similar correlations of tumor thickness with survival have been found by others. Spiro et al.' found a significant difference in survival comparing tumors < 2 mm to those > 2 mm thick. Multivariate analysis comparing tumor thickness to tumor size revealed that tumor thickness was a more important predictor of prognosis. They were also able to correlate thickness with regional recurrence. Similarly, Mohit-Tabataba et al2 showed a significant increase in cervical lymph node metastases with lesions < 1.5 mm thick as compared to those > 1.5 mm. Urist et ~l.~, studied buccal mucosa carcinomas and found a significant decrease in survival when comparing tumors < 6 mm in tumor thickness to those > 6 mm. One difference between this study and those cited above is the larger values for tumor thickness used by us. Only seven patients in our study had tumors measuring 2 mm or less whereas Spiro et al.' and Mohit-Tabataba et af.* had 43 of 105 patients and 57 of 84 patients with T1 and T2 tumors, respectively, measuring less than 2 mm. In those seven patients, there were no regional metastases and no deaths from disease, which is in agreement with the other studies. Close et al6 also looked at tumor thickness along with vascular invasion and perineural invasion to determine their predictive value for lymph node metastasis. In their study, only intravascular invasion was found to correlate with regional recurrence. Close et al6 suggest that their patient population had larger tumor sizes and, therefore, were more likely to have thicker tumors. The same holds true for our study. An important consideration, however, is the difficulties in measuring tumor thickness. With malignant melanoma, as defined by Bre~low,~ strict criteria for measuring tumors are defined with the measurement taken from the deepest point of invasion to the top of the granular cell layer of the overlying epidermis. Measurements are taken at right angles to the skin surface. Breslow' noted two main problems in measurement: poor sampling of the lesion and variation in apparent thickness due to changes in the angle of sectioning. In measuring mucosal tumors in a retrospective study, there often is not a mucosal surface in the slide to use as a reference point. Furthermore, there is often a significant amount of keratin and debris TABLE 5. Relationship of Thickness Class and Penneural Invasion Perineural invasion Thickness class Yes No Percent Total A B C on the surface, which as noted earlier, were not included in our measurements. For some patients, we had three different measurements depending on whether one chose the mucosal surface, the tumor surface, or the ulcer base as a starting point. In this study, we always chose the largest measurement, which might also account for our larger thickness measurements. Another problem was tangential cuts. In some of our cases, recuts of the paraffin blocks were done when a confident estimate of perpendicular measurement could not be done. Finally, and perhaps most important, were errors identified in sectioning of the tumor. There were some tumors in which only the periphery was sampled. not evaluating the greatest depth in the center (Fig. 1, diagram 3). Therefore, we could not be sure the deepest portion of the tumor was being measured. It thus becomes apparent why different institutions may have different results based on tumor thickness. Only with a prospective study which identifies precise guidelines for processing the tumor and measuring thickness can comparisons among institutions be made. It was expected that perineural invasion would correlate with both survival and regional recurrence. This association has been confirmed by Again, it is important to have a precise definition of perineural invasion. Larson et al8 clearly showed that once tumor involves the perineural space, it can spread in both a longitudinal and radial fashion through the planes of least resistance. In the presence of perineural spread, the likelihood of tumor extending beyond margins of resection is increased. Thus, tumor can continue to grow leading to local, regional, and distant recurrence. It is also important to note the strong relationship between perineural invasion and tumor thickness suggesting that perineural invasion is an important factor responsible for decreased survival with increasing thickness. Identifying perineural invasion is a tedious task involving a careful review of all tumor slides. The presence of perineural invasion should make one to strongly consider adding elective neck dissection and/or radiation therapy to the resection of the primary tumor. The presence of intralymphatic tumor emboli correlated with the development of regional disease, although
8 1202 CANCER September Vol. 64 there was no correlation with survival. Regardless, our study supports elective treatment of the neck when intralymphatic tumor emboli are found. Although Close el al6 were able to find a significant number of patients with intravascular tumor emboli, they did not require tumor attachment to the vessel well or thrombus formation. Given our criteria, there were too few patients for any conclusions to be drawn. One question our study attempted to answer was the management of the NO neck. Our data shows a strong positive correlation between tumor size, perineural invasion, intralymphatic tumor emboli, and the development of regional recurrence. Furthermore, if we only looked at tumors that were < 2 mm as Spiro et al.' did, tumor thickness correlates as well. Although our numbers were small and not statistically significant, there is a suggestion that patients undergoing elective neck dissections who are found to have occult nodes have an increased survival as compared to those patients who are observed and treated when recurrence develops. This finding is suggested by earlier studies in our institution as well9 Therefore, in the presence of tumor size > 2 cm, tumor thickness > 2 mm, perineural invasion or intralymphatic tumor emboli, one should strongly consider elective treatment of the neck. REFERENCES I. Spiro HR, Huvos AG, Wong GY et a/. Predictive value of tumor thickness in squamous carcinoma confined to the tongue and floor of the mouth. Am J Surg 1986; 152: Mohit-Tabatabai MA, Sobel MJ. Rush BF et a/. Relation ofthickness of floor of mouth Stage 1 and II cancers to regional metastasis. Am JSitrg 1986; 152: Urist MM, OBrien CJ, Soong SJ ef a/. Squamous cell carcinoma of the buccal mucosa: Analysis of prognostic factors. Am J Sitrg 1987; 154: So0 KC, Carter RL, OBrien CJ et d. Prognostic implications of perineural spread in squamous carcinomas of the head and neck. Laryngoscope 1986; 96:1145-I Goepfert H, Dichtel WJ, Medina TE ef al. Perineural invasion in squamous cell carcinoma of the head and neck. Am J Surg 1984; 148: Close LG, Burns DK, Reisch J et a/. Microvascular invasion in cancer of the oral cavity and oropharynx. Arch Otolaryngol Head Neck Szrrg 1987; 113: Breslow A. Prognostic factors in the treatment of cutaneous melanoma. J Cutan Pathol 1979; Larson DL, Rodin AE, Roberts DK ef al. Perineural lymphatics: Myth or fact. Am J Surg 1966; Cunningham MJ, Johnson JT, Myers EN ef a/. Cervical lymph node metastasis after local excision of early squamous cell carcinoma of the oral cavity. Am JSurg 1986; 152:
Image. 3.11.3 SW Review the anatomy of the EAC and how this plays a role in the spread of tumors.
Neoplasms of the Ear and Lateral Skull Base Image 3.11.1 SW What are the three most common neoplasms of the auricle? 3.11.2 SW What are the four most common neoplasms of the external auditory canal (EAC)
More informationRESEARCH EDUCATE ADVOCATE. Just Diagnosed with Melanoma Now What?
RESEARCH EDUCATE ADVOCATE Just Diagnosed with Melanoma Now What? INTRODUCTION If you are reading this, you have undergone a biopsy (either of a skin lesion or a lymph node) or have had other tests in which
More informationBreast cancer close to the nipple: Does this carry a higher risk ofaxillary node metastasesupon diagnosis?
Breast cancer close to the nipple: Does this carry a higher risk ofaxillary node metastasesupon diagnosis? Erin I. Lewis, BUSM 2010 Cheri Nguyen, BUSM 2008 Priscilla Slanetz, M.D., MPH Al Ozonoff, Ph.d.
More informationORIGINAL ARTICLE. Results of Salvage Treatment of the Neck in Patients With Oral Cancer
Results of Salvage Treatment of the in Patients With Oral Cancer Luiz P. Kowalski, MD, PhD ORIGINAL ARTICLE Background: About 50% of the patients with neck recurrences after the treatment of oral squamous
More informationATLAS OF HEAD AND NECK PATHOLOGY THYROID PAPILLARY CARCINOMA
Papillary carcinoma is the most common of thyroid malignancies and occurs in all age groups but particularly in women under 45 years of age. There is a high rate of cervical metastatic disease and yet
More informationManagement of the Clinically Negative Neck in Early Squamous Cell Carcinoma of the Oral Cavity
Otolaryngol Clin N Am 38 (2005) 37 46 Management of the Clinically Negative Neck in Early Squamous Cell Carcinoma of the Oral Cavity Scharukh Jalisi, MD Department of Otolaryngology-Head and Neck Surgery,
More informationOBJECTIVES By the end of this segment, the community participant will be able to:
Cancer 101: Cancer Diagnosis and Staging Linda U. Krebs, RN, PhD, AOCN, FAAN OCEAN Native Navigators and the Cancer Continuum (NNACC) (NCMHD R24MD002811) Cancer 101: Diagnosis & Staging (Watanabe-Galloway
More informationLip Cancer: Treatment & Reconstruction
Lip Cancer: Treatment & Reconstruction GBMC - Head & Neck Cancer Grand Rounds Elizabeth E. Redd, M.D. With the assistance of Ira Papel, M.D. Patrick Byrne, M.D. Lip Cancer: Treatment & Reconstruction Anatomic
More informationSurgical Management of Papillary Microcarcinoma 趙 子 傑 長 庚 紀 念 醫 院 林 口 總 院 一 般 外 科
Surgical Management of Papillary Microcarcinoma 趙 子 傑 長 庚 紀 念 醫 院 林 口 總 院 一 般 外 科 Papillary microcarcinoma of thyroid Definition latent aberrant thyroid occult thyroid carcinoma latent papillary carcinoma)
More informationSUNY DOWNSTATE MEDICAL CENTER SURGERY GRAND ROUNDS February 28, 2013 VERENA LIU, MD ROSEANNA LEE, MD
SUNY DOWNSTATE MEDICAL CENTER SURGERY GRAND ROUNDS February 28, 2013 VERENA LIU, MD ROSEANNA LEE, MD Case Presentation 35 year old male referred from PMD with an asymptomatic palpable right neck mass PMH/PSH:
More informationEMR Can anyone do this?
EMR Can anyone do this? Norio Fukami, MD University of Colorado Piecemeal resection? 1 Endoscopic mucosal resection (EMR) and Endoscopic submucosal dissection (ESD) Endoscopic removal of premalignant or
More informationCurrent Status and Perspectives of Radiation Therapy for Breast Cancer
Breast Cancer Current Status and Perspectives of Radiation Therapy for Breast Cancer JMAJ 45(10): 434 439, 2002 Masahiro HIRAOKA, Masaki KOKUBO, Chikako YAMAMOTO and Michihide MITSUMORI Department of Therapeutic
More informationMelanoma The Skin Understanding Cancer
Melanoma A form of cancer that begins in melanocytes (cells that make the pigment melanin). It may begin in a mole (skin melanoma), but can also begin in other pigmented tissues, such as in the eye or
More informationObjectives. Mylene T. Truong, MD. Malignant Pleural Mesothelioma Background
Imaging of Pleural Tumors Mylene T. Truong, MD Imaging of Pleural Tumours Mylene T. Truong, M. D. University of Texas M.D. Anderson Cancer Center, Houston, TX Objectives To review tumors involving the
More informationChanges in Breast Cancer Reports After Second Opinion. Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain
Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain Second Opinion in Breast Pathology Usually requested when a patient is referred
More informationKidney Cancer OVERVIEW
Kidney Cancer OVERVIEW Kidney cancer is the third most common genitourinary cancer in adults. There are approximately 54,000 new cancer cases each year in the United States, and the incidence of kidney
More informationSentinel Lymph Node Mapping for Endometrial Cancer. Locke Uppendahl, MD Grand Rounds
Sentinel Lymph Node Mapping for Endometrial Cancer Locke Uppendahl, MD Grand Rounds Endometrial Cancer Most common gynecologic malignancy in US estimated 52,630 new cases in 2014 estimated 8,590 deaths
More informationUpdate on thyroid cancer surveillance and management of recurrent disease. Minimally invasive thyroid surgery
Update on thyroid cancer surveillance and management of recurrent disease Minimally invasive thyroid surgery July 2006 Michael W. Yeh, MD Program Director, Endocrine Surgery Assistant Professor, David
More informationHow to report Upper GI EMR/ESD specimens
Section of Pathology and Tumour Biology How to report Upper GI EMR/ESD specimens Dr.H.Grabsch Warning. Most of the criteria, methodologies, evidence presented in this talk are based on studies in early
More information9. Discuss guidelines for follow-up post-thyroidectomy for cancer (labs/tests) HH
9. Discuss guidelines for follow-up post-thyroidectomy for cancer (labs/tests) HH Differentiated thyroid cancer expresses the TSH receptor on the cell membrane and responds to TSH stimulation by increasing
More informationChapter 2 Staging of Breast Cancer
Chapter 2 Staging of Breast Cancer Zeynep Ozsaran and Senem Demirci Alanyalı 2.1 Introduction Five decades ago, Denoix et al. proposed classification system (tumor node metastasis [TNM]) based on the dissemination
More informationLymph Nodes and Cancer What is the lymph system?
Lymph Nodes and Cancer What is the lymph system? Our bodies have a network of lymph vessels and lymph nodes. (Lymph is pronounced limf.) This network is a part of the body s immune system. It collects
More informationRotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma
Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma Medical Expert: Breast Rotation Specific Competencies/Objectives 1.0 Medical History
More informationTreating Melanoma S kin Cancer A Quick Guide
Treating Melanoma Skin Cancer A Quick Guide Contents This is a brief summary of the information on Treating melanoma skin cancer from our website. You will find more detailed information on the website.
More informationBreast Cancer: from bedside and grossing room to diagnoses and beyond. Adriana Corben, M.D.
Breast Cancer: from bedside and grossing room to diagnoses and beyond Adriana Corben, M.D. About breast anatomy Breasts are special organs that develop in women during puberty when female hormones are
More informationThe TV Series. www.healthybodyhealthymind.com INFORMATION TELEVISION NETWORK
The TV Series www.healthybodyhealthymind.com Produced By: INFORMATION TELEVISION NETWORK ONE PARK PLACE 621 NW 53RD ST BOCA RATON, FL 33428 1-800-INFO-ITV www.itvisus.com 2005 Information Television Network.
More informationTHYROID CANCER. I. Introduction
THYROID CANCER I. Introduction There are over 11,000 new cases of thyroid cancer each year in the US. Females are more likely to have thyroid cancer than men by a ratio of 3:1, and it is more common in
More informationSCD Case Study. Most malignant lesions of the tonsil are either lymphosarcoma or carcinoma.
SCD Case Study Dry Mouth This case study details a patient who has experienced xerostomia as a result of treatment for squamous cell carcinoma of the left tonsil involving surgery followed by deep x-ray
More information7 th Edition Staging. AJCC 7 th Edition Staging. Disease Site Webinar. Melanoma of Skin. Overview. This webinar is sponsored by
AJCC 7 th Edition Staging Melanoma of Skin Donna M. Gress, RHIT, CTR Validating science. Improving patient care. This presentation was supported by the Cooperative Agreement Number DP13-1310 from The Centers
More informationPost-PET Restaging Cancer Form National Oncologic PET Registry
Post-PET Restaging Cancer Form National Oncologic PET Registry Facility ID #: Registry Case Number: Patient Name: Your patient had a PET scan on: mm/dd/yyyy. The PET scan was done for restaging of (cancer
More informationA912: Kidney, Renal cell carcinoma
A912: Kidney, Renal cell carcinoma General facts of kidney cancer Renal cell carcinoma, a form of kidney cancer that involves cancerous changes in the cells of the renal tubule, is the most common type
More informationDiagnosis and Prognosis of Pancreatic Cancer
Main Page Risk Factors Reducing Your Risk Screening Symptoms Diagnosis Treatment Overview Chemotherapy Radiation Therapy Surgical Procedures Lifestyle Changes Managing Side Effects Talking to Your Doctor
More informationSQUAMOUS CELL CARCINOMA
SQUAMOUS CELL CARCINOMA What are the aims of this leaflet? This leaflet has been written to help you understand more about squamous cell carcinomas of the skin. It tells you what they are, what causes
More informationHow to treat early gastric cancer. Surgery
How to treat early gastric cancer Surgery Mark I. van Berge Henegouwen Department of Surgery, AMC, Amsterdam Director upper GI surgical unit Academic Medical Center Upper GI surgery at AMC 100 oesophagectomies
More informationGUIDELINES FOR THE MANAGEMENT OF LUNG CANCER
GUIDELINES FOR THE MANAGEMENT OF LUNG CANCER BY Ali Shamseddine, MD (Coordinator); as04@aub.edu.lb Fady Geara, MD Bassem Shabb, MD Ghassan Jamaleddine, MD CLINICAL PRACTICE GUIDELINES FOR THE TREATMENT
More informationAn individual is considered an incident case only once per lifetime.
1 DERM 4 MALIGNANT MELANOMA; SKIN Includes Invasive Malignant Melanoma Only; Does Not Include Secondary Melanoma; For Malignant Melanoma In-Situ, See Corresponding Case Definition Background This case
More informationDiagnosis and Treatment of Common Oral Lesions Causing Pain
Diagnosis and Treatment of Common Oral Lesions Causing Pain John D. McDowell, DDS, MS University of Colorado School of Dentistry Chair, Oral Diagnosis, Medicine and Radiology Director, Oral Medicine and
More informationThe common feature of all melanomas is the cell of origin, the
1664 COMMUNICATION The American College of Surgeons Commission on Cancer and the American Cancer Society The National Cancer Data Base Report on Cutaneous and Noncutaneous Melanoma A Summary of 84,836
More informationGENERAL CODING. When you review old cases that were coded to unknown, make corrections based on guidelines in effect at the time of diagnosis.
GENERAL CODING When you review old cases that were coded to unknown, make corrections based on guidelines in effect at the time of diagnosis. Exception: You must review and revise EOD coding for prostate
More informationPediatric Oncology for Otolaryngologists
Pediatric Oncology for Otolaryngologists Frederick S. Huang, M.D. Division of Hematology/Oncology Department of Pediatrics The University of Texas Medical Branch Grand Rounds Presentation to Department
More informationExplanation of your PAP smear
Explanation of your PAP smear Approximately 5-10% of PAP smears in the United States are judged to be abnormal. Too often, the woman who receives this news worries that she already has, or will develop,
More informationRecommendations for cross-sectional imaging in cancer management, Second edition
www.rcr.ac.uk Recommendations for cross-sectional imaging in cancer management, Second edition Breast cancer Faculty of Clinical Radiology www.rcr.ac.uk Contents Breast cancer 2 Clinical background 2 Who
More informationLesions, and Masses, and Tumors Oh My!!
Lesions, and Masses, and Tumors Oh My!! Presented by: Susan Ward, CPC, CPC-H, CPC-I, CPCD, CEMC, CPRC 1 1 CPT GUIDELINES Agenda CPT DEFINITIONS OP REPORT CASES 2 Definitions Cyst - a closed sac having
More informationTravel Distance to Healthcare Centers is Associated with Advanced Colon Cancer at Presentation
Travel Distance to Healthcare Centers is Associated with Advanced Colon Cancer at Presentation Yan Xing, MD, PhD, Ryaz B. Chagpar, MD, MS, Y Nancy You MD, MHSc, Yi Ju Chiang, MSPH, Barry W. Feig, MD, George
More informationBreast Cancer. The Pathology report gives an outline on direction of treatment. It tells multiple stories to help us understand the patient s cancer.
Breast Cancer What Does the Pathology Report Say Normal Cells The Pathology report gives an outline on direction of treatment. It tells multiple stories to help us understand the patient s cancer. Non-Invasive
More informationLocal control in ductal carcinoma in situ treated by excision alone: incremental benefit of larger margins
The American Journal of Surgery 190 (2005) 521 525 George Peter s Award Winner Local control in ductal carcinoma in situ treated by excision alone: incremental benefit of larger margins Heather R. MacDonald,
More informationCancer of the Cervix
Cancer of the Cervix WOMENCARE A Healthy Woman is a Powerful Woman (407) 898-1500 A woman's cervix (the opening of the uterus) is lined with cells. Cancer of the cervix occurs when those cells change,
More information7. Prostate cancer in PSA relapse
7. Prostate cancer in PSA relapse A patient with prostate cancer in PSA relapse is one who, having received a primary treatment with intent to cure, has a raised PSA (prostate-specific antigen) level defined
More informationFrequently Asked Questions About Ovarian Cancer
Media Contact: Gerri Gomez Howard Cell: 303-748-3933 gerri@gomezhowardgroup.com Frequently Asked Questions About Ovarian Cancer What is ovarian cancer? Ovarian cancer is a cancer that forms in tissues
More informationSmall Cell Lung Cancer
Small Cell Lung Cancer Types of Lung Cancer Non-small cell carcinoma (NSCC) (87%) Adenocarcinoma (38%) Squamous cell (20%) Large cell (5%) Small cell carcinoma (13%) Small cell lung cancer is virtually
More informationThe utility of endoscopic ultrasonography and endoscopy in the endoscopic mucosal resection of early gastric cancer
Gut 1999;45:599 604 599 The utility of endoscopic ultrasonography and endoscopy in the endoscopic mucosal resection of early gastric cancer S Ohashi, K Segawa, S Okamura, M Mitake, H Urano, M Shimodaira,
More informationReport series: General cancer information
Fighting cancer with information Report series: General cancer information Eastern Cancer Registration and Information Centre ECRIC report series: General cancer information Cancer is a general term for
More informationConcurrent Chemotherapy and Radiotherapy for Head and Neck Cancer
Concurrent Chemotherapy and Radiotherapy for Head and Neck Cancer Ryan J. Burri; Nancy Y. Lee Published: 03/23/2009 Abstract and Introduction Abstract Head and neck cancer is best managed in a multidisciplinary
More informationHow To Treat Lung Cancer At Cleveland Clinic
Treatment Guide Lung Cancer Management The Chest Cancer Center at Cleveland Clinic, which includes specialists from the Respiratory Institute, Taussig Cancer Institute and Miller Family Heart & Vascular
More informationBREAST CANCER PATHOLOGY
BREAST CANCER PATHOLOGY FACT SHEET Version 4, Aug 2013 This fact sheet was produced by Breast Cancer Network Australia with input from The Royal College of Pathologists of Australasia I m a nurse and know
More informationManagement of Postmenopausal Women with T1 ER+ Tumors: Options and Tradeoffs. Case Study. Surgery. Lumpectomy and Radiation
Management of Postmenopausal Women with T1 ER+ Tumors: Options and Tradeoffs Michael Alvarado, MD Associate Professor of Surgery University of California San Francisco Case Study 59 yo woman with new palpable
More informationPathologic Assessment Of The Breast And Axilla After Preoperative Therapy
Pathologic Assessment Of The Breast And Axilla After Preoperative Therapy W. Fraser Symmans, M.D. Associate Professor of Pathology UT M.D. Anderson Cancer Center Pathologic Complete Response (pcr) Proof
More informationCHAPTER 14 STAGING AND REPORTING
CHAPTER 14 STAGING AND REPORTING Staging of Colorectal Cancer refers to the classification of the tumour according to the extent of spread in a manner that has a clinically useful correlation with prognosis.
More informationTumor Budding as a Useful Prognostic Marker in T1-Stage Squamous Cell Carcinoma of the Esophagus
2013;108:42 46 Tumor Budding as a Useful Prognostic Marker in T1-Stage Squamous Cell Carcinoma of the Esophagus HITOSHI TERAMOTO, MD, 1 * MASAHIKO KOIKE, MD, PhD, 1 CHIE TANAKA, MD, PhD, 1 SUGURU YAMADA,
More informationMetastatic Cervical Cancer s/p Radiation Therapy, Radical Hysterectomy and Attempted Modified Internal Hemipelvectomy
Metastatic Cervical Cancer s/p Radiation Therapy, Radical Hysterectomy and Attempted Modified Internal Hemipelvectomy Sarah Hutto,, MSIV Marc Underhill, M.D. January 27, 2009 Past History 45 yo female
More informationPANCREATIC AND PERIAMPULLARY TUMORS: PANCREATICODUODENECTOMY. Dr. Shailesh V. Shrikhande
PANCREATIC AND PERIAMPULLARY TUMORS: PANCREATICODUODENECTOMY Dr. Shailesh V. Shrikhande Associate Professor & Consultant Surgeon GI and HPB Surgical Oncology Tata Memorial Hospital, Mumbai INDIA HELICAL
More informationUs TOO University Presents: Understanding Diagnostic Testing
Us TOO University Presents: Understanding Diagnostic Testing for Prostate Cancer Patients Today s speaker is Manish Bhandari, MD Program moderator is Pam Barrett, Us TOO International Made possible by
More informationDoes Resection of an Intact Breast Primary Improve Survival in Metastatic Breast Cancer?
rvival in Metastatic Breast Cancer? Review Article [1] July 01, 2007 By Seema A. Khan, MD [2] The recommended primary treatment approach for women with metastatic breast cancer and an intact primary tumor
More informationProstate Cancer. Treatments as unique as you are
Prostate Cancer Treatments as unique as you are UCLA Prostate Cancer Program Prostate cancer is the second most common cancer among men. The UCLA Prostate Cancer Program brings together the elements essential
More informationRecurrent & Persistent Papillary Thyroid Cancer Central Nodal Dissection vs. Node-Picking Patterns of Nodal Metastases Recurrent Laryngeal Nerve,
Recurrent & Persistent Papillary Thyroid Cancer Central Nodal Dissection vs. Node-Picking Patterns of Nodal Metastases Recurrent Laryngeal Nerve, Larynx, Trachea, & Esophageal Management Robert C. Wang,
More informationADJUVANT RADIATION FOR MALIGNANT MELANOMA
ADJUVANT RADIATION FOR MALIGNANT MELANOMA Effective Date: February 2014 The recommendations contained in this guideline are a consensus of the Alberta Cutaneous Tumour Team and are a synthesis of currently
More informationLoco-regional Recurrence
Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer AGO AGO e. e. V. V. Loco-regional Recurrence Loco-regional Recurrence Version 2002: Brunnert / Simon Versions 2003 2012: Audretsch
More informationTreatment Volume and Technique
RADIATION THERAPY The standard of care for early lesions is surgical resection; however, selected patients with small central lesions may be considered for definitive radiation, particularly when the lesions
More informationUnderstanding Your Surgical Options For Breast Cancer
RADIATION THERAPY SYMPTOM MANAGEMENT CANCER INFORMATION Understanding Your Surgical Options For Breast Cancer In this booklet you will learn about: Role of surgery in breast cancer diagnosis and treatment
More informationTogether, The Strength
DECATUR County Indiana Together, The Strength to Fight Cancer Barbara Taylor, MD Cancer Committee Chairperson Rahul Dewan, DO Radiation Oncology Cancer Liasion Jaime Ayon, MD Medical Oncology/ Hematology
More informationLung Cancer Treatment Guidelines
Updated June 2014 Derived and updated by consensus of members of the Providence Thoracic Oncology Program with the aid of evidence-based National Comprehensive Cancer Network (NCCN) national guidelines,
More informationUpdate on Mesothelioma
November 8, 2012 Update on Mesothelioma Intro incidence and nomenclature Update on Classification Diagnostic specimens Morphologic features Epithelioid Histology Biphasic Histology Immunohistochemical
More informationCarcinoma of the Cervix. Kathleen M. Schmeler, MD Associate Professor Department of Gynecologic Oncology
Carcinoma of the Cervix Kathleen M. Schmeler, MD Associate Professor Department of Gynecologic Oncology Cervical Cancer Treatment Treatment Microinvasive (Stage IA1): Simple (extrafascial) hysterectomy/cone
More informationReport with statistical data from 2007
2008 Cancer Program Annual Report with statistical data from 2007 Lake Cumberland Regional Hospital 305 Langdon Streett Somerset, KY 42503 Telephone: 606-679-7441 Fax: 606-678-9919 Cancer Committee Mullai,
More informationINTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER Prospective Mesothelioma Staging Project
INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER Prospective Mesothelioma Staging Project Data Forms and Fields in CRAB Electronic Data Capture System - Reduced Set - Pivotal data elements for developing
More informationBridging Techniques. What s between EMR and Traditional Surgery? Elisabeth C. McLemore, MD, FACS, FASCRS
Bridging Techniques What s between EMR and Traditional Surgery? Elisabeth C. McLemore, MD, FACS, FASCRS Associate Professor of Surgery Assistant Program Director, General Surgery Residency Disclosures
More informationNew strategies in anticancer therapy
癌 症 診 療 指 引 簡 介 及 臨 床 應 用 New strategies in anticancer therapy 中 山 醫 學 大 學 附 設 醫 院 腫 瘤 內 科 蔡 明 宏 醫 師 2014/3/29 Anti-Cancer Therapy Surgical Treatment Radiotherapy Chemotherapy Target Therapy Supportive
More informationYour Guide to the Breast Cancer Pathology Report
Your Guide to the Breast Cancer Pathology Report Developed for you by Breastcancer.org is a nonprofit organization dedicated to providing education and information on breast health and breast cancer. The
More informationductal carcinoma in situ (DCIS)
Understanding ductal carcinoma in situ (DCIS) and deciding about treatment Understanding ductal carcinoma in situ (DCIS) and deciding about treatment Developed by National Breast and Ovarian Cancer Centre
More informationGeneral Rules SEER Summary Stage 2000. Objectives. What is Staging? 5/8/2014
General Rules SEER Summary Stage 2000 Linda Mulvihill Public Health Advisor NCRA Annual Meeting May 2014 National Center for Chronic Disease Prevention and Health Promotion Division of Cancer Prevention
More informationUnderstanding ductal carcinoma in situ (DCIS) and deciding about treatment
Understanding ductal carcinoma in situ (DCIS) and deciding about treatment Developed by National Breast and Ovarian Cancer Centre Funded by the Australian Government Department of Health and Ageing Understanding
More informationA918: Prostate: adenocarcinoma
A918: Prostate: adenocarcinoma General facts of prostate cancer The prostate is about the size of a walnut. It is just below the bladder and in front of the rectum. The tube that carries urine (the urethra)
More informationYour Guide to Express Critical Illness Insurance Definitions
Your Guide to Express Critical Illness Insurance Definitions Your Guide to EXPRESS Critical Illness Insurance Definitions This guide to critical illness definitions will help you understand the illnesses
More informationTNM Staging of Head and Neck Cancer and Neck Dissection Classification
QUICK REFERENCE GUIDE TO TNM Staging of Head and Neck Cancer and Neck Dissection Classification Fourth Edition 2014 All materials in this ebook are copyrighted by the American Academy of Otolaryngology
More informationAnalysis of Prostate Cancer at Easter Connecticut Health Network Using Cancer Registry Data
The 2014 Cancer Program Annual Public Reporting of Outcomes/Annual Site Analysis Statistical Data from 2013 More than 70 percent of all newly diagnosed cancer patients are treated in the more than 1,500
More informationThe Whipple Operation for Pancreatic Cancer: Optimism vs. Reality. Franklin Wright UCHSC Department of Surgery Grand Rounds September 11, 2006
The Whipple Operation for Pancreatic Cancer: Optimism vs. Reality Franklin Wright UCHSC Department of Surgery Grand Rounds September 11, 2006 Overview Pancreatic ductal adenocarcinoma Pancreaticoduodenectomy
More informationDetection and staging of recurrent prostate cancer is still one of the important clinical problems in prostate cancer. A rise in PSA or biochemical
Summary. 111 Detection and staging of recurrent prostate cancer is still one of the important clinical problems in prostate cancer. A rise in PSA or biochemical recurrence (BCR) is the first sign of recurrent
More informationEvidence tabel Lokaal palliatieve behandelingen
Auteurs, jaartal Mate van bewijs Studie type Follow-up Populatie (incl. steekproef-grootte) Patienten kenmerken Interventie Controle Resultaten Conclusie Opmerkingen, commentaar Hartgrink, 2002 The Netherlands
More informationSurgical Staging of Endometrial Cancer
Surgical Staging of Endometrial Cancer I. Endometrial Cancer Surgical Staging Overview Uterine cancer types: carcinomas type I and type II, sarcomas, carcinosarcomas Hysterectomy with BSO Surgical Staging
More informationSurgical guidelines for the management of breast cancer
Available online at www.sciencedirect.com EJSO xx (2009) S1eS22 www.ejso.com Guidelines Surgical guidelines for the management of breast cancer Contents Association of Breast Surgery at BASO 2009 Introduction...
More informationIV. DEFINITION OF LYMPH NODE GROUPS (FIGURE 1) Level IA: Submental Group
IV. DEFINITION OF LYMPH NODE GROUPS (FIGURE 1) Fig. 1 The level system is used for describing the location of lymph nodes in the neck: Level I, submental and submandibular group; Level II, upper jugular
More informationLifeProtect. Cancer Cover. For Intermediary Use Only
LifeProtect Cancer Cover For Intermediary Use Only There are few families in Ireland that have been unaffected by cancer. In fact, 1 in 3 men and 1 in 4 women in Ireland* will suffer from cancer at some
More informationPET/CT in Lung Cancer
PET/CT in Lung Cancer Rodolfo Núñez Miller, M.D. Nuclear Medicine and Diagnostic Imaging Section Division of Human Health International Atomic Energy Agency Vienna, Austria GLOBOCAN 2012 #1 #3 FDG-PET/CT
More informationStaging Head and Neck Cancers Transitioning to the Seventh Edition of The AJCC Cancer Staging Manual
Staging Head and Neck Cancers Transitioning to the Seventh Edition of The AJCC Cancer Staging Manual Jatin P. Shah, MD, PhD (Hon) Memorial Sloan-Kettering Cancer Center New York, New York The American
More informationHow To Treat A Uterine Sarcoma
EVERYONE S GUIDE FOR CANCER THERAPY Malin Dollinger, MD, Ernest H. Rosenbaum, MD, Margaret Tempero, MD, and Sean Mulvihill, MD 4 th Edition 2001 Uterus: Uterine Sarcomas Jeffrey L. Stern, MD Uterine sarcomas
More informationEndoscopic mucosal resection for treatment of early gastric cancer
Gut 2001;48:225 229 225 Endoscopic mucosal resection for treatment of early gastric cancer H Ono, H Kondo, T Gotoda, K Shirao, H Yamaguchi, D Saito, K Hosokawa, T Shimoda, S Yoshida Department of Endoscopy
More informationTable 16a Multiple Myeloma Average Annual Number of Cancer Cases and Age-Adjusted Incidence Rates* for 2002-2006
Multiple Myeloma Figure 16 Definition: Multiple myeloma forms in plasma cells that are normally found in the bone marrow. 1 The plasma cells grow out of control and form tumors (plasmacytoma) or crowd
More informationExperience of Radioactive Need le Implants in the Institute of Radioth erapy Hospital Kuala lumpur
Experience of Radioactive Need le Implants in the Institute of Radioth erapy Hospital Kuala lumpur G C C Lim*, M T Azhar**, *Institute of Rad.iotherapy and Oncology, Hospital Kuala Lumpur, **Faculty of
More informationCancer of the Cardia/GE Junction: Surgical Options
Cancer of the Cardia/GE Junction: Surgical Options Michael A Smith, MD Associate Chief Thoracic Surgery Center for Thoracic Disease St Joseph s Hospital and Medical Center Phoenix, AZ Michael Smith, MD
More informationThyroid Cancer: Resection, Dissection, Surveillance and Recurrence. Cord Sturgeon, MD
Thyroid Cancer: Resection, Dissection, Surveillance and Recurrence Cord Sturgeon, MD Associate Professor of Surgery Northwestern University Feinberg School of Medicine Director of Endocrine Surgery Chicago,
More information